Eric Snijder to Middle East Respiratory Syndrome Coronavirus
This is a "connection" page, showing publications Eric Snijder has written about Middle East Respiratory Syndrome Coronavirus.
Connection Strength
0.572
-
The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2. J Virol. 2020 11 09; 94(23).
Score: 0.184
-
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model. Virus Res. 2017 01 15; 228:7-13.
Score: 0.139
-
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014 Aug; 58(8):4875-84.
Score: 0.117
-
A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. PLoS Biol. 2020 06; 18(6):e3000715.
Score: 0.045
-
Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication. mBio. 2017 11 21; 8(6).
Score: 0.037
-
Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 2014 Dec 12; 289(50):34667-82.
Score: 0.030
-
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness. J Clin Virol. 2020 Oct; 131:104594.
Score: 0.011
-
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2923-6.
Score: 0.008